TYRA Tyra Biosciences, Inc.

8-K Current Report

Filed: March 4, 2026

Health Care

Pharmaceutical Preparations

Tyra Biosciences, Inc. (TYRA) 8-K current report filed with SEC EDGAR on March 4, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• Equity raise: 4,000,000 shares sold at $31.50/share to a single large institutional buyer via block transaction
• Gross proceeds $126.0M before fees, executed under existing ATM program registered May 2025

+3 more insights

Other Tyra Biosciences, Inc. 8-K Filings

8-K Mar 2, 2026

Get deeper insights on Tyra Biosciences, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.